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The  benzodiazepine  subtype-212212 is  expressed  in  P19 cells.
Stimulating  GABAAergic  pathway  produces  an intracellular  alkalinization.
Stimulating  GABAAergic  pathway  modulates  downstream  PRMT  activity.
The  GABAAergic  mediated  PRMT  activation  is  impaired  in a  mouse  model  of FXS.
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Changes  in cytoplasmic  pH  are  known  to regulate  diverse  cellular  processes  and  inﬂuence  neuronal  activ-
ities. In neurons,  the intracellular  alkalization  is shown  to occur  after  stimulating  several  channels  and
receptors.  For example,  it has  previously  demonstrated  in  P19  neurons  that  a sustained  intracellular  alka-
linization  can  be mediated  by the  Na+/H+ antiporter.  In addition,  the  benzodiazepine  binding  subtypes  of
the  -amino  butyric  acid  type  A (GABAA)  receptor  mediate  a  transient  intracellular  alkalinization  when
they  are  stimulated.  Because  the  activities  of  many  enzymes  are  sensitive  to  pH  shift,  here  we investigate
the  effects  of  intracellular  pH modulation  resulted  from  stimulating  GABAA receptor  on  the protein  argi-
nine methyltransferases  (PRMT)  activities.  We  show  that  the  major  benzodiazepine  subtype  (21, 22,
12) is  constitutively  expressed  in  both  undifferentiated  P19  cells  and  retinoic  acid (RA)  differentiated
P19 neurons.  Furthermore  stimulation  with  diazepam  and, diazepam  plus  muscimol  produce  an  intra-
cellular  alkalinization  that  can  be detected  ex vivo  with  the  ﬂuorescence  dye.  The  alkalinization  results
in  signiﬁcant  perturbation  in protein  arginine  methylation  activity  as measured  in  methylation  assays
with  speciﬁc  protein  substrates.  Altered  protein  arginine  methylation  is also  observed  when  cells  are
treated  with  the  GABAA agonist  muscimol  but not  an  antagonist,  bicuculline.  These  data  suggest  that
pH-dependent  and pH-independent  methylation  pathways  can  be  activated  by  GABAAergic  stimulation,
which  we  veriﬁed  using  hippocampal  slice  preparations  from  a  mouse  model  of  fragile  X syndrome.
rs.  Pu© 2014  The  Autho
. IntroductionThe maintenance of intracellular pH is crucial for cell survival
12]. Accordingly; cells have several redundant means of sensing
Abbreviations: PRMT, protein arginine methyltransferase; GABA,  -amino
utyric acid; SAH, S–adenosyl–homocysteine; KO, knock-out; FXS, fragile X syn-
rome; WT,  wild-type; RA, retinoic acid.
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304-3940/© 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open acce
y-nc-nd/3.0/).blished  by Elsevier  Ireland  Ltd.  This  is an  open  access  article  under  the CC
BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
and regulating intracellular pH [3]. Among the most prominent
sentinels are several types of ion transporters and receptors.
The Na+/H+ antiporter is shown to constitutively expressed in
embryonal carcinoma P19 cells, and the retinoic acid (RA) induced
P19 neurons differentiation is coupled to downstream effectors by
protein arginine methyltransferase (PRMT) activity [20]. Thus, a
variety of PRMT substrates exhibit a unique pH dependence, which
can be altered by NH4Cl-mediated depolarization. Indeed, apply-
ing NH4Cl to P19 cells in vitro results in sustained intracellular
alkalinization which can be easily monitored using pH sensitive
ﬂuorescent dyes such as SNARF-1AM [20].
ss article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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The ionotropic GABA type A (GABAA) and the metabotropic
ABA type B receptors mediate GABA stimulated synaptic inhibi-
ion; under certain conditions the GABAA receptors can produce
 transient intracellular alkalinization. This occurs when spe-
iﬁc subtypes of the receptor that respond to benzodiazepams
ssemble into functional receptors. For instance the subtype
ontaining two 1 subunits, two 2 subunits, and one 2 sub-
nit, the major subtype found in brain [14] is one example.
ut other receptor subtypes containing the 2 subunit, which is
equired for forming the benzodiazepine binding pocket, can also
ediate this type of signaling. Thus, adding diazepam to hip-
ocampal slices that had been previously stimulated result in
 marked increase in the magnitude and extent of intracellular
lkalinization [1].
P19 neurons are shown to produce functional GABAA [5,16]
eceptors. To test the hypothesis that the PRMT activities are mod-
lated by GABAA receptor mediated intracellular alkalinization,
e investigated whether GABAA agonist/antagonists were cou-
led downstream to protein arginine methylation using P19 cells
nd hippocampus slide preparation. The results of these studies,
eported here suggest that GABAA receptors are linked to protein
rginine methylation by pH-dependent and pH-independent path-
ays.
. Materials and methods
.1. Buffers and chemicals
HMTase Buffer is prepared as described [9]. PBS and SNARF-
AM were purchased from Invitrogen. Protease inhibitors were
urchased from Roche. Muscimol and bicuculline were obtained
rom Ascent. Diazepam, and SAH were obtained from Sigma. [3H]-
-Adenosyl-l-methionine 15 Ci/mmol was purchased from MP
iomedical, Inc.
.2. Proteins, peptides and antibodies
Histone H3 and H4 were purchased from Roche Applied Bio-
ciences. Myelin basic protein (mouse) was obtained from Sigma.
OLA1 was purchased from GenWay Biotech, Inc. Biotinylated
mD1 peptide, biotin-KREAVAGRGRGRGRGRGRGRGRGRGGPRR,
as synthesized by CPC Scientiﬁc. The antibody to the  sub-
nit of the GABAA receptor, anti-dimethylarginine antibody SYM10
Ab, and anti-Histone H4(R3)SMe2 pAb were purchased from
illipore. The antibody to the 1 subunit of the GABAA recep-
or was purchased from GenWay Biotech, Inc. Anti-Hsp70c
Ab  was obtained from Stress-Gen. Anti-MAP2 antibody was
rom Santa Cruz, and anti-PAPB mAB  was obtained from Cell
ignaling.
.3. Cell culture
P19 cells were cultured as described [19]. Differentiation
f rapidly growing cultures into neuronal and glial cells was
ccomplished accordingly [13]. All of the results presented here
orrespond to cells cultured for 6–8 days in the presence or absence
f 0.1 M RA.
.4. Mice and hippocampal slices
WT  and fragile X KO mice were obtained from a colony of
ongenic C57BL/fragile X KO mice at the New York State Insti-
ute for Basic Research (IBR) [21]. Fragile KO mice were derived
y repeatedly backcrossed the FVB/N-129 hybrid mice carrying
he fmri knockout mutation originally provided by B. Oostra and
. Willemsen to male C57BL (JAX). The WT control animals were Letters 572 (2014) 38–43 39
littermates of fragile KO mice. The animals were treated in accor-
dance with the principles and procedures of the National Institutes
of Health Guidelines for the Care and Use  of Laboratory Ani-
mals. The mice were euthanized by CO2 asphyxiation as instructed
by the local Institutional Animal Care and Use Committee
at IBR.
Hippocampal slices were prepared as described [6]. Slices were
perfused with artiﬁcial cerebral spinal ﬂuid continuously bubbled
with 95% O2/5% CO2 to maintain the pH near 7.4. The temperature
was maintained at 34 –36◦C.
2.5. RNA isolation and RT-PCR
RNA was extracted from P19 cells or mouse tissues using
RNAeasy mRNA mini columns (Qiagen). One microgram of RNA
was used to prepare ﬁrst strand cDNA (Invitrogen). Aliquots
of the cDNAs were ampliﬁed using the following primers:
GABAA–1, F-5 ′AGCTATACCCCTAACTTAGCCAGG and R-5 ′AGAAA-
GCAATTCTCGGTGCAGAGGAC; GABAA-2, F-5 ′TGAGATGGCCACA-
TCCGAAGCAGT and R-5 ′CTCACGGAAGGCTGTAGTTTAGTTCA;
GABAA–2S, F-5 ′AAGAAAAACCCTGCCCCTACCATTG and R-
5 ′GTCTCCATAAGATTCAGCGAATAAC. Primers are based on the
sequences of mouse GABAA receptor subunits 1, 2 and 2S; Gen-
Bank accession numbers NM 012050, NM 008070, NM 177408,
respectively. Reaction products were resolved on agarose gels
along with appropriate size markers.
2.6. Western blotting and immunoﬂuorescence microscopy
Proteins were prepared from cultured cells or mouse tissues
for Western blotting as described [18]. The blots were detected
by primary antibody SYM10 or Hsp70c and corresponding HRP-
conjugated secondary antibody (Pierce), and developed using the
PicoTag system (Pierce).
Cells were processed for immunohistochemistry as described
[19]. The cells were incubated with designated primary antibody
and then with secondary antibody (Alexa Fluor 488 or Alexa Fluor
568, Molecular Probes). Fluorescence was  detected with an Eclipse
90i dual laser-scanning confocal microscope (NIKON). Images were
acquired at 20–40× magniﬁcation Equivalent regions of interest
(ROI) within each image are presented.
2.7. In vitro methylation assays
In vitro methylation by the endogenous methyltransferases
(MTs) of the proteins in cell lysates or various substrate proteins
was performed as described [20], so was  the in vitro methylation of
the biotinylated-SmD1 peptide [20].
2.8. pH-Dependent activation of P19 cells
Retinoic differentiated P19 cells were loaded with the pH-
sensing ﬂuorescent dye SNARF-1AM, as described [20]. The cells
were treated or not treated with diazepam (10 M),  musicmol
(100 M),  bicuculline (60 M)  or combination of them. The images
were captured and the results were computed as described [20].2.9. Statistical analysis
One-way ANOVA and student Newman–Keuls post-hoc testing
were used.
40 R.B. Denman et al. / Neuroscience Letters 572 (2014) 38–43
Fig. 1. P19 cells express functional GABAA receptors. (A) RNA isolated from mouse brain cortex (C), undifferentiated P19 cells (U) and RA differentiated P19 cells was  subject to
RT-PCR using primers to the 1, 2 and 2S subunits of the GABAA receptor. (B) (Upper panel) RA differentiated P19 cells were immuonstained with an antibody that detects
the  essential  subunit of the GABAA receptor (green) and the neuronal marker MAP2 (red). Punctate GABAA receptor staining is evident in the processes of differentiated cells
(yellow  arrows) and in the nucleus and soma of undifferentiated cells (white arrows). (Lower panel) The cells were also stained with an antibody that detects the 1 subunit
of  the GABAA receptor. In this case too staining is observed in the processes of differentiated cells (yellow arrows) and in the soma of undifferentiated cells (white arrows).
These  results are consistent with the RT-PCR results in (A). (C) Retinoic differentiated P19 cells were loaded with the pH-sensing ﬂuorescent dye SNARF-1AM. Subsequently,
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100  M)  and subject to confocal ﬂuorescence microscopy. The results show an incre
ells  (P < 1 × 10−4), which is indicative of an intracellular alkalinization. Difference
olor  in this ﬁgure legend, the reader is referred to the web  version of this article.)
. Results
.1. Mouse P19 cells express functional GABAA receptors
PRMT in embryonic P19 cells is shown to be modulated by
ntracellular alkalinization occurring through the Na+/H+ antiporter
20]; however there are other receptors whose activation can alter
ntracellular alkalinization. One of these is the GABAA receptor
1]. To determine whether GABAAergic stimulation also results in
ltered PRMT-dependent methylation we ﬁrst determined whether
A differentiated P19 cells contained functional GABAA receptors.
ig. 1A shows that P19 cells express a variety of GABAA receptor
ubunit mRNAs. Included among these was the 2S subunit mRNA
hose expression is necessary for modulation of benzodiazepam
2,16] and is pre-requisite for intracellular alkalinization. We  next
xamined the expression of GABAA receptor subunit proteins by
mmunohistochemistry. Here we show that both undifferentiated10 M),  diazepam and muscimol (10 M and 100 M,  respectively) or muscimol
 this ratio in diazepam-treated cells (P < 1 × 10−4), and diazepam–muscimol-treated
 the control are indicated by the asterisks. (For interpretation of the references to
P19 cells and differentiated P19 neurons express the essential
GABAA receptor  subunit and the GABAA 1 receptor subunit
(Fig. 1B, top and bottom panels, respectively), which also helps
mediate benzodiazepine binding. These results substantially reca-
pitulate the previous work [5].
As expression does not always result in function we sought a
means of testing whether the GABAA receptor subunits expressed
P19 cells were functional. For this we  chose a ﬂuorescence-based
indicator reaction using SNARF-1AM, one of a family of dyes the
ratio of whose emission wavelengths change as a function of pH
[17]. Thus, treating cells with agents that result in intracellular alka-
linization should lead to an increase in the ratio, F640/F580. Quite
simply cells were loaded with SNARF-1AM for 30 min  and the unab-
sorbed dye was  washed out. The dye-loaded cells were then treated
with the GABAA antagonist bicuculline, the modulator diazepam,
or a combination of diazepam and the GABAA agonist musci-
mol, stimulated at a wavelength of 480 nm and the ﬂuorescence
R.B. Denman et al. / Neuroscience Letters 572 (2014) 38–43 41
Fig. 2. GABAAergic stimulation alters PRMT substrate methylation in differentiated P19 neurons. (A) P19 cells were treated for 15 min. with 100 M muscimol (M), 10 M
diazepam (D) 60 M bicuculline (B), or left untreated (C). Protein extracts from the cells were subject to in vitro methylation with the indicated substrates resolved by
SDS–PAGE and then subject to ﬂuorography (histone H4, NOLA1, MBP), or Western blotting (Histone H4(R3)Sme2). (B) Top, western blot of the treated p19 cells extracts
probed  with anti-SYM 10 pAb. Lower, the protein load for each lane are shown by the commassie stained gel. (C) P19 cell extracts analogous to those in (A) along with one
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bbtained by treating cells with 10 M diazepam and 100 M muscimol (D/M) we
H-SAM [20]. The incorporated radioactivity was measured by liquid scintillation co
or  four independent experiments run in quadruplicate is shown. The asterisk and d
ntensities at 640 nm and 580 nm simultaneously recorded for
0 min. Fig. 1C shows the time averaged ratio F640/F580 for these
reatments from 4 representative experiments. As expected, treat-
ent with the bicuculline had no effect on the F640/F580 ratio
nd hence no effect upon intracellular pH. In contrast, both
iazepam and diazepam with muscimol produced robust increases
n F640/F580, which is consistent with the alkalinization of the intra-
ellular milieu.
.2. PRMT-dependent methylation is altered by diazepam and
uscimol
We  previously demonstrated that intracellular alkalinization
ia NH4Cl treatment led to differential changes in PRMT-mediated
ethylation of its substrates in the absence of changes to PRMT
xpression levels [20]. With a similar approach, we examined the
nﬂuence GABAA receptor modulatory agents had on the meth-
lation of particular exogenous PRMT substrates. Speciﬁcally, we
reated RA differentiated P19 cells with muscimol, diazepam or
icuculline, harvested the cells and extracted the proteins. Theseject to in vitro methylation using an SmD1 peptide substrate supplemented with
g and compared to that of the untreated control extract. The ratio of treated/control
 asterisk denotes signiﬁcant differences compared to the control.
protein extracts were then compared to untreated differentiated
P19 cell extracts for their ability to methylate three exogenous pro-
teins histone H4, NOLA1 or MBP, Fig. 2A. In addition, we examined
the expression of an endogenous protein-p37 in RA differentiated
P19 cells after various treatments with an antibody (SYM10) that
recognizes symmetrically dimethylated arginine residues, Fig. 2B.
It is clear from the data that bicuculline treatment had little to no
effect on any of the substrates examined (Fig. 2A). In contrast, P19
cells treated with the GABAA agonist muscimol, and its modulator,
diazepam resulted in substrate-speciﬁc alterations in their meth-
ylation proﬁles. In particular, we observed a signiﬁcant decrease
in muscimol-treated cell extracts to methylate histone H4, NOLA1,
and MBP, Fig. 2A, top, 3rd and bottom panels respectively.
Histone H4 is known to be methylated at R3. To determine the
effect of its symmetrical methylation at R3, we probed western blot
of H4 methylation reactions with an antibody (anti-H4(R3)Sme2)
that recognizes H4 when it is symmetrical methylated at R3 and
the result shows that muscimol treatment had almost no effect on
histone H4 symmetric dimethylation of residue R3 with respect to
the control (Fig. 2A, 2nd panel).
4 cience Letters 572 (2014) 38–43
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Fig. 3. GABAAergic stimulation alters PRMT substrate methylation in hippocampal
slices from Fmr1 WT and KO mice. (A) Hippocampal slices from WT,  WT treated for
15  min. with 10 M diazepam and 100 M muscimol (WTD/M), Fmr1 KO or Fmr1 KO
mice  treated for 15 min. with 10 M diazepam and 100 M muscimol (KOD/M). Pro-
tein extracts were subject to in vitro methylation using a SmD1 peptide as described
above. The ratio of treated/untreated for the WT and KO for four independent exper-
iments run in quadruplicate is shown. The double asterisk denotes the signiﬁcant2 R.B. Denman et al. / Neuros
Diazepam alone was also found to alter the methylation of
hese proteins. In this case NOLA1 and MBP  methylation were both
levated with respect to the control (Fig. 2A, 3rd and bottom pan-
ls, respectively). In contrast, neither the methylation of histone
4 (Fig. 2A, top panel), nor the symmetric dimethylation of the
3 residue of histone H4 (Fig. 2A, 2nd panel) was signiﬁcantly
ffected by diazepam. Similarly, diazepam had no effect on the
xpression of the endogenous p37 when probing the western blot
f diazepam-treated p19 extract with a SYM10 antibody (Fig. 2B,
op). The combined data suggest that GABAAergic stimulation of
19 cells does not much affect the pathway leading to symmetric
emethylation, Fig. 2A, 2nd panel and Fig. 2B top panel. This agrees
ith previous work showing that PRMT5-dependent methylation
f insect cell lysates is not greatly affected by changes in pH [20].
.3. Synergic effect of diazepam and muscimol on
RMT-dependent methylation
In addition to the simple exogenous substrate assay described
bove, we used an afﬁnity capture a peptide methylation assay [20]
o quantitatively examine the effect that GABAAergic agents had on
he methylation activity of P19 neurons, Fig. 2C. The peptide used
n this assay corresponds to the RG-rich region of the spliceosomal
rotein SmD1 and is shown to be methylated by human recom-
inant PRMTs at various pHs [20]. Like all of the other exogenous
ubstrates examined in Fig. 2A, we found that bicuculline had no
ffect on the SmD1 methylation (P = 0.81). However, in contrast to
he other substrates methylation of the SmD1 peptide increased
igniﬁcantly compared to the controls in muscimol-treated cells
P = 0.046), while there was no signiﬁcant change between the con-
rols and diazepam-treated extracts (P = 0.36). In addition, we also
ssessed SmD1 methylation in cells that had been treated with
uscimol and diazepam. As discussed above, diazepam with mus-
imol modulates intracellular pH in P19 neurons (Fig. 1C). The
esults, shown in Fig. 2C demonstrate that while diazepam had no
ffect on PRMT activity, it potentiated the muscimol-induced PRMT
ctivation as measured by SmD1 methylation (Pmuscimol = 0.046
ersus PDiaz/muscimol = 0.001). Again, these data highlight the unique
odulatory activity of these GABAAergic agents toward various
ethylation substrates.
.4. Altered PRMT activity in fragile X mouse
The results above suggested that a combination of diazepam
nd muscimol increased the methylation of the SmD1 peptide and
hat was elicited by stimulating a pH-dependent pathway in P19
eurons. To independently conﬁrm this we sought a model sys-
em to further investigate this phenomenon. We  chose to compare
mD1 methylation using a readily available mouse model of frag-
le X syndrome (FXS). Speciﬁcally, we applied diazepam (10 M)
nd muscimol (100 M)  to hippocampal slices prepared from WT
nd Fmr1 KO mice for 15 min, and then measured SmD1 methyla-
ion levels after washout of diazepam and muscimol. The rationale
or this choice is relatively straight forward. First, it has been
hown in GABAA 2 subunit knockdown mice that the hippocam-
us is one of the most prevalent sites of 2 expression [4]. Second,
ABAA metabolism is substantially mis-regulated in Fmr1 KO mice:
he inhibitory neurotransmission in the amygdala is substantially
isrupted [15] and the GABAA  and GABAA  subunits are sub-
tantially decreased [10,11]. Third, the 1 and 2 subunit mRNA are
igniﬁcantly under-expressed in Fmr1 KO mice [7]. Lastly, protein
rginine methylation is also altered in Fmr1 KO versus WT  mice
8]. Thus, one might expect to see an increase in SmD1 methyla-
ion in WT  slices treated with diazepam and muscimol and either
o change or decreased SmD1 methylation in KO slices. As in the
ase of P19 neurons, while there was a robust increase in SmD1
difference between the WT  ratio and the KO ratio. (B) Hippocampal slices analogous
to  those in (A) were subject to in vitro methylation with the indicated substrates
resolved by SDS–PAGE and then subject to ﬂuorography (histone H4, NOLA1, MBP),
or  Western blotting (Hsp70c, p37). Note: the Hsp70c blot represents only the protein
loads, it cannot be methylated.
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ethylation in WT  hippocampal slices treated with diazepam and
uscimol, there was a signiﬁcant decrease in KO hippocampal
lices (P = 0.00134), Fig. 3A. In contrast, we found no apparent
hange between the WT  and the FMR1 KO hippocampal slices in
heir ability to methylate histone H4, MBP, NOLA1 and p37 after
he diazepam and muscimol treatment, Fig. 3B. Thus, these data
onﬁrm that GABAAergic stimulation with the agonist muscimol
nd the modulator diazepam operates through a pH-dependent
athway to alter protein arginine methylation.
. Discussion
In summary we have demonstrated in two different model
ystems that GABAAergic agents can signal through both pH-
ndependent and pH-dependent pathways to alter downstream
rotein arginine methylation targets. Furthermore, the pattern of
hanges elicited by GABAAergic agents differ from those occur-
ing when P19 neurons are stimulated with the depolarizing agent,
H4Cl [20], demonstrating the extreme sensitivity of this bifur-
ated pathway toward modulation. Speciﬁcally, the changes in
xogenous substrate methylation observed upon muscimol stim-
lation in the absence of diazepam reﬂect the activation of a
H-independent methylation pathway in P19 neurons (Figs. 1C and
A and C).
GABAA receptors are heteropentameric ligand-gated Cl− ion
hannels that are formed from a combination of 19 different sub-
nits derived from 7 subunit classes [14]. While receptors (21,
2, 12) represent the major receptor subtype it is important
o note that each GABAA receptor subtype formed gives rise to
ts unique set of electrophysiological and pharmacological prop-
rties. Critical for these studies is the fact that benzodiazepines like
iazepam bind to a site formed from the interface between the
1–3,5 and 2 subunits and can signiﬁcantly enhance the magni-
ude and extent intracellular alkalinization of the CA1 region of the
ippocampus following electrophysiological stimulation admin-
stered to the contralateral CA3 region [1]. To address whether
here were any combinatorial changes in methylation induced
y the presence of muscimol and diazepam we assessed SmD1
ethylation in both P19 neurons and hippocampal slices that
ad been treated with both agents. As shown in Figs. 2C and 3A,
o-application of diazepam strengthened the muscimol-induced
RMT activity which reﬂects the activation of a pH-dependent
ethylation pathway (compare to Fig. 1C).
Alterations in protein arginine methylation following GABAA
eceptor stimulation may  occur for a variety of reasons as well as
rom changes in PRMT activity. One of these would be a change
n PRMT expression. Nevertheless, we did not observe alteration
n the expression levels of the primary asymmetric and symmet-
ic PRMTs in cells treated with mucsicmol, bicuculline, diazepam
nd mucsicmol with diazepam. Therefore, any change in protein
rginine methylation toward either endogenous or exogenous pro-
ein methylation substrates that may  be observed following GABAA
eceptor stimulation of P19 cells probably occurs via a change in
RMT activity.
As a major inhibitory receptor in the brain, GABAA receptor is
nvolved in regulating all aspects of brain function. Consequently,
he impaired GABAAergic-stimulated PRMT activation observed
n the FMR1 KO hippocampal slices suggests PRMT contributes
o the abnormal GABAAergic transmission associated with FXS.
rotein methylation can affect its interaction with other factors
ncluding proteins and RNAs and also its subcellular localization.
uture studies will be directed to 1) identify the speciﬁc PRMT
[
[ Letters 572 (2014) 38–43 43
that is regulated by GABAAergic pathway and affected in the
mouse model of FXS and 2) compare methylation levels in nor-
mal, fragile x, and fragile x autistic patients by examining PMRT
activity.
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